Citigroup’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-701,517
| Closed | -$36.8M | – | 7833 |
|
|
2020
Q3 | $36.8M | Buy |
701,517
+438,043
| +166% | +$18.1M | 0.02% | 597 |
|
|
2020
Q2 | $8.77M | Buy |
263,474
+202,344
| +331% | +$6.44M | 0.01% | 1401 |
|
|
2020
Q1 | $1.66M | Buy |
61,130
+2,675
| +5% | +$74.5K | ﹤0.01% | 2661 |
|
|
2019
Q4 | $1.15M | Sell |
58,455
-93,144
| -61% | -$1.49M | ﹤0.01% | 3615 |
|
|
2019
Q3 | $1.97M | Buy |
151,599
+25,832
| +21% | +$312K | ﹤0.01% | 2884 |
|
|
2019
Q2 | $1.57M | Buy |
125,767
+66,154
| +111% | +$878K | ﹤0.01% | 3127 |
|
|
2019
Q1 | $866K | Sell |
59,613
-150,683
| -72% | -$1.92M | ﹤0.01% | 3560 |
|
|
2018
Q4 | $2.32M | Buy |
210,296
+199,887
| +1,920% | +$2.78M | ﹤0.01% | 2533 |
|
|
2018
Q3 | $274K | Sell |
10,409
-36,704
| -78% | -$992K | ﹤0.01% | 4923 |
|
|
2018
Q2 | $963K | Sell |
47,113
-18,071
| -28% | -$388K | ﹤0.01% | 3400 |
|
|
2018
Q1 | $1.18M | Sell |
65,184
-1,503
| -2% | -$25.1K | ﹤0.01% | 3092 |
|
|
2017
Q4 | $931K | Buy |
66,687
+57,386
| +617% | +$776K | ﹤0.01% | 3411 |
|
|
2017
Q3 | $172K | Sell |
9,301
-4,435
| -32% | -$74.1K | ﹤0.01% | 5111 |
|
|
2017
Q2 | $232K | Buy |
13,736
+9,954
| +263% | +$152K | ﹤0.01% | 4669 |
|
|
2017
Q1 | $50K | Sell |
3,782
-183,298
| -98% | -$2.87M | ﹤0.01% | 5702 |
|
|
2016
Q4 | $2.81M | Buy |
187,080
+126,171
| +207% | +$1.67M | ﹤0.01% | 2532 |
|
|
2016
Q3 | $712K | Buy |
60,909
+50,868
| +507% | +$598K | ﹤0.01% | 3576 |
|
|
2016
Q2 | $108K | Sell |
10,041
-35,057
| -78% | -$362K | ﹤0.01% | 5018 |
|
|
2016
Q1 | $417K | Buy |
45,098
+38,834
| +620% | +$418K | ﹤0.01% | 4331 |
|
|
2015
Q4 | $93K | Buy |
6,264
+4,589
| +274% | +$76.8K | ﹤0.01% | 5430 |
|
|
2015
Q3 | $27K | Sell |
1,675
-691
| -29% | -$14.1K | ﹤0.01% | 5831 |
|
|
2015
Q2 | $54K | Sell |
2,366
-1,504
| -39% | -$30K | ﹤0.01% | 5481 |
|
|
2015
Q1 | $59K | Sell |
3,870
-384,742
| -99% | -$5M | ﹤0.01% | 5453 |
|
|
2014
Q4 | $4.68M | Sell |
388,612
-27,337
| -7% | -$312K | ﹤0.01% | 1843 |
|
|
2014
Q3 | $4.72M | Buy |
415,949
+287,804
| +225% | +$3.28M | ﹤0.01% | 1882 |
|
|
2014
Q2 | $1.55M | Sell |
128,145
-73,604
| -36% | -$869K | ﹤0.01% | 2650 |
|
|
2014
Q1 | $2.35M | Buy |
201,749
+179,850
| +821% | +$3.05M | ﹤0.01% | 2249 |
|
|
2013
Q4 | $387K | Buy |
21,899
+7,847
| +56% | +$132K | ﹤0.01% | 4039 |
|
|
2013
Q3 | $202K | Buy |
14,052
+10,532
| +299% | +$161K | ﹤0.01% | 4146 |
|
|
2013
Q2 | $53K | Buy |
+3,520
| New | +$46.5K | ﹤0.01% | 5348 |
|
Citigroup's MNTA Position: Q4 2020 in Review
Citigroup sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 701,517 shares — an estimated $36.8M sold.
Citigroup first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $36.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Citigroup reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 701,517 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $36.8M.
- Citigroup first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Citigroup's Momenta Pharmaceuticals, Inc. position peaked at $36.8M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.